Table 1 Clinical and demographic data of patients with ANCA + CGN.
From: Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis
ANCA CGN Patient | Age (years) | Gender (F/M) | Urinary Gremlin (ug/gCr) | Serum Creatinine (mg/dl) | Crescent (%) | Masson (% staining area) | ANCA | URINALYSIS | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
IFI | ELISA (U/ml) | Prot (mg/dl) | RBC (cells/field) | Casts | |||||||
1 | 41 | F | 1408 | 4.1 | 46 | 4 | c | 5 PR3 | 75 | 0–2 | (—) |
2 | 81 | F | 36 | 1.9 | 29 | 2.7 | p | >100 MPO | 75 | 10–20 | (—) |
3 | 83 | F | 665 | 4.6 | 67 | 1.8 | p | >100 MPO | 150 | 20–30 | hyaline granular |
4 | 63 | F | 333 | 6.1 | 86 | 1.6 | p | 20 MPO | 500 | 5–10 | hyaline |
5 | 68 | F | 78 | 1.7 | 38 | 2.0 | p | 9 MPO | 500 | 5–10 | hyaline |
6 | 72 | F | 413 | 10.6 | 58 | 10.9 | p | 93 MPO | 150 | 80–90 | granular |
7 | 67 | M | 892 | 7.8 | 75 | 2.1 | p | >100 MPO | 300 | 20–50 | hyaline |
8 | 33 | F | 644 | 5.8 | 23 | 8.7 | p | 73 MPO | 150 | 20–50 | RBCs granular |
9 | 60 | M | 417 | 4.3 | 30 | 8.4 | p | 9 MPO | 300 | 20–30 | (—) |
10 | 56 | F | 362 | 6.8 | 40 | 5.1 | p | >100 MPO | 300 | 10–20 | RBCs |
11 | 64 | F | 292 | 4.3 | 63 | 5.5 | p | 10 MPO | 500 | 0–2 | hyaline |
12 | 59 | M | 490 | 3.5 | 50 | 10.8 | p | nt | 150 | 60–70 | (—) |
13 | 60 | F | 75 | 1.3 | 36 | 7.1 | p | 84 MPO | 150 | 10–20 | hyaline granular |
14 | 67 | M | 132 | 5.8 | 100 | 0.3 | p | 76 MPO | 75 | 80–90 | (—) |
15 | 56 | M | 59 | 0.8 | 40 | 2.8 | p | 18 MPO | 75 | 80–90 | hyaline granular |
16 | 21 | F | 159 | 0.9 | 40 | 15.8 | p | nt | 75 | 20–50 | hyaline |
17 | 69 | F | 96 | 7.7 | 50 | 2.8 | p | 9 MPO | 150 | 20–50 | granular |
18 | 60 | M | 168 | 6.9 | 50 | 6.8 | p | 9 MPO | 100 | 30–40 | (—) |
19 | 29 | F | 256 | 2.1 | 100 | 4.0 | p | 38 MPO | 75 | 20–50 | hyaline granular |
20 | 61 | M | 100 | 7.9 | 71 | 5.8 | c | 7.4 PR3 | 30 | 20–30 | (—) |
